# Crimson Wine Group, Ltd: financial statements, quarterly

CWGL · OTC · CIK 1562151 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cwgl.md) · [Financials](/companies/cwgl/financials.md) · [Filings](/companies/cwgl/filings.md) · [Insiders](/companies/cwgl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cwgl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [18.0](/filings/0001562151-24-000045.md) | [21.4 d](/filings/0001562151-25-000007.md) | [15.9](/filings/0001562151-25-000012.md) | [17.2](/filings/0001562151-25-000029.md) | [16.9](/filings/0001628280-25-050240.md) | [22.9 d](/filings/0001628280-26-018796.md) | [14.5](/filings/0001628280-26-032083.md) | [17.0](/filings/0001628280-26-054306.md) | [13.3](/filings/0001628280-25-050240.md) | [20.3 d](/filings/0001628280-26-018796.md) | [18.3](/filings/0001628280-26-032083.md) | [20.5](/filings/0001628280-26-054306.md) |
| Cost of revenue | $m | [9.6](/filings/0001562151-24-000045.md) | [11.7 d](/filings/0001562151-25-000007.md) | [8.2](/filings/0001562151-25-000012.md) | [8.5](/filings/0001562151-25-000029.md) | [8.8](/filings/0001628280-25-050240.md) | [12.4 d](/filings/0001628280-26-018796.md) | [7.8](/filings/0001628280-26-032083.md) | [9.3](/filings/0001628280-26-054306.md) | [7.0](/filings/0001628280-25-050240.md) | [10.3 d](/filings/0001628280-26-018796.md) | [10.4](/filings/0001628280-26-032083.md) | [11.9](/filings/0001628280-26-054306.md) |
| Gross profit | $m | [8.4](/filings/0001562151-24-000045.md) | [9.7 d](/filings/0001562151-25-000007.md) | [7.7](/filings/0001562151-25-000012.md) | [8.8](/filings/0001562151-25-000029.md) | [8.1](/filings/0001628280-25-050240.md) | [10.5 d](/filings/0001628280-26-018796.md) | [6.6](/filings/0001628280-26-032083.md) | [7.8](/filings/0001628280-26-054306.md) | [6.3](/filings/0001628280-25-050240.md) | [10.0 d](/filings/0001628280-26-018796.md) | [7.9](/filings/0001628280-26-032083.md) | [8.6](/filings/0001628280-26-054306.md) |
| Selling, general and administrative | $m | [8.0](/filings/0001562151-24-000045.md) | [7.8 d](/filings/0001562151-25-000007.md) | [8.6](/filings/0001562151-25-000012.md) | [8.7](/filings/0001562151-25-000029.md) | [8.4](/filings/0001628280-25-050240.md) | [8.5 d](/filings/0001628280-26-018796.md) | [8.2](/filings/0001628280-26-032083.md) | [8.2](/filings/0001628280-26-054306.md) | [7.5](/filings/0001628280-25-050240.md) | [8.3 d](/filings/0001628280-26-018796.md) | [8.5](/filings/0001628280-26-032083.md) | [8.5](/filings/0001628280-26-054306.md) |
| Operating income | $m | [0.4](/filings/0001562151-24-000045.md) | [1.9 d](/filings/0001562151-25-000007.md) | [(1.1)](/filings/0001562151-25-000012.md) | [(0.0)](/filings/0001562151-25-000029.md) | [(0.3)](/filings/0001628280-25-050240.md) | [1.5 d](/filings/0001628280-26-018796.md) | [(1.5)](/filings/0001628280-26-032083.md) | [(0.4)](/filings/0001628280-26-054306.md) | [(1.2)](/filings/0001628280-25-050240.md) | [(0.6) d](/filings/0001628280-26-018796.md) | [(0.6)](/filings/0001628280-26-032083.md) | [0.0](/filings/0001628280-26-054306.md) |
| Interest expense | $m | [0.2](/filings/0001562151-23-000072.md) | [0.3 d](/filings/0001562151-24-000011.md) | [0.2](/filings/0001562151-24-000017.md) | [0.1](/filings/0001562151-25-000029.md) | [0.2](/filings/0001628280-25-050240.md) | [0.2 d](/filings/0001628280-26-018796.md) | [0.2](/filings/0001628280-26-032083.md) | [0.1](/filings/0001628280-26-054306.md) | [0.2](/filings/0001628280-25-050240.md) | [0.2 d](/filings/0001628280-26-018796.md) | [0.5](/filings/0001628280-26-032083.md) | [0.5](/filings/0001628280-26-054306.md) |
| Income tax | $m | [0.6](/filings/0001562151-24-000045.md) | [0.6 d](/filings/0001562151-25-000007.md) | [(0.2)](/filings/0001562151-25-000012.md) | [0.1](/filings/0001562151-25-000029.md) | [0.0](/filings/0001628280-25-050240.md) | [0.5 d](/filings/0001628280-26-018796.md) | [(0.4)](/filings/0001628280-26-032083.md) | [(0.1)](/filings/0001628280-26-054306.md) | [0.4](/filings/0001628280-25-050240.md) | [0.3 d](/filings/0001628280-26-018796.md) | [(0.2)](/filings/0001628280-26-032083.md) | [(0.1)](/filings/0001628280-26-054306.md) |
| Net income | $m | [1.7](/filings/0001562151-24-000045.md) | [1.5 d](/filings/0001562151-25-000007.md) | [(0.6)](/filings/0001562151-25-000012.md) | [0.1](/filings/0001562151-25-000029.md) | [0.0](/filings/0001628280-25-050240.md) | [1.3 d](/filings/0001628280-26-018796.md) | [(0.9)](/filings/0001628280-26-032083.md) | [(0.1)](/filings/0001628280-26-054306.md) | [0.9](/filings/0001628280-25-050240.md) | [0.7 d](/filings/0001628280-26-018796.md) | [(0.6)](/filings/0001628280-26-032083.md) | [(0.3)](/filings/0001628280-26-054306.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001562151-24-000045.md) | not reported | [(0.03)](/filings/0001562151-25-000012.md) | [0.01](/filings/0001562151-25-000029.md) | [0.00](/filings/0001628280-25-050240.md) | not reported | [(0.05)](/filings/0001628280-26-032083.md) | [(0.01)](/filings/0001628280-26-054306.md) | [0.05](/filings/0001628280-25-050240.md) | not reported | [(0.03)](/filings/0001628280-26-032083.md) | [(0.02)](/filings/0001628280-26-054306.md) |
| Basic EPS | $ per share | [0.08](/filings/0001562151-24-000045.md) | not reported | [(0.03)](/filings/0001562151-25-000012.md) | [0.01](/filings/0001562151-25-000029.md) | [0.00](/filings/0001628280-25-050240.md) | not reported | [(0.05)](/filings/0001628280-26-032083.md) | [(0.01)](/filings/0001628280-26-054306.md) | [0.05](/filings/0001628280-25-050240.md) | not reported | [(0.03)](/filings/0001628280-26-032083.md) | [(0.02)](/filings/0001628280-26-054306.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.3](/filings/0001562151-23-000072.md) | [22.8](/filings/0001562151-25-000007.md) | [22.6](/filings/0001562151-24-000017.md) | [16.9](/filings/0001562151-24-000038.md) | [24.3](/filings/0001562151-24-000045.md) | [21.0](/filings/0001628280-26-018796.md) | [12.7](/filings/0001562151-25-000012.md) | [22.2](/filings/0001562151-25-000029.md) | [23.6](/filings/0001628280-25-050240.md) | [20.6](/filings/0001628280-26-054306.md) | [14.3](/filings/0001628280-26-032083.md) | [11.8](/filings/0001628280-26-054306.md) |
| Current assets | $m | [96.8](/filings/0001562151-23-000072.md) | [98.6](/filings/0001562151-25-000007.md) | [92.6](/filings/0001562151-24-000017.md) | [92.8](/filings/0001562151-24-000038.md) | [100](/filings/0001562151-24-000045.md) | [98.0](/filings/0001628280-26-018796.md) | [93.1](/filings/0001562151-25-000012.md) | [94.2](/filings/0001562151-25-000029.md) | [101](/filings/0001628280-25-050240.md) | [109](/filings/0001628280-26-054306.md) | [128](/filings/0001628280-26-032083.md) | [121](/filings/0001628280-26-054306.md) |
| Total assets | $m | [221](/filings/0001562151-23-000072.md) | [222](/filings/0001562151-25-000007.md) | [214](/filings/0001562151-24-000017.md) | [215](/filings/0001562151-24-000038.md) | [222](/filings/0001562151-24-000045.md) | [218](/filings/0001628280-26-018796.md) | [211](/filings/0001562151-25-000012.md) | [212](/filings/0001562151-25-000029.md) | [218](/filings/0001628280-25-050240.md) | [215](/filings/0001628280-26-054306.md) | [243](/filings/0001628280-26-032083.md) | [236](/filings/0001628280-26-054306.md) |
| Current liabilities | $m | [14.6](/filings/0001562151-23-000072.md) | [14.6](/filings/0001562151-25-000007.md) | [9.0](/filings/0001562151-24-000017.md) | [9.7](/filings/0001562151-24-000038.md) | [17.7](/filings/0001562151-24-000045.md) | [13.1](/filings/0001628280-26-018796.md) | [8.6](/filings/0001562151-25-000012.md) | [9.6](/filings/0001562151-25-000029.md) | [14.5](/filings/0001628280-25-050240.md) | [11.3](/filings/0001628280-26-054306.md) | [11.1](/filings/0001628280-26-032083.md) | [11.5](/filings/0001628280-26-054306.md) |
| Total liabilities | $m | [33.2](/filings/0001562151-23-000072.md) | [33.9](/filings/0001562151-25-000007.md) | [27.8](/filings/0001562151-24-000017.md) | [28.3](/filings/0001562151-24-000038.md) | [36.0](/filings/0001562151-24-000045.md) | [31.6](/filings/0001628280-26-018796.md) | [26.3](/filings/0001562151-25-000012.md) | [27.0](/filings/0001562151-25-000029.md) | [32.0](/filings/0001628280-25-050240.md) | [28.7](/filings/0001628280-26-054306.md) | [56.9](/filings/0001628280-26-032083.md) | [50.0](/filings/0001628280-26-054306.md) |
| Long-term debt | $m | [16.8](/filings/0001562151-23-000072.md) | [16.5](/filings/0001562151-25-000007.md) | [16.3](/filings/0001562151-24-000017.md) | [16.0](/filings/0001562151-24-000038.md) | [15.7](/filings/0001562151-24-000045.md) | [15.4](/filings/0001628280-26-018796.md) | [15.1](/filings/0001562151-25-000012.md) | [14.8](/filings/0001562151-25-000029.md) | [14.6](/filings/0001628280-25-050240.md) | [14.3](/filings/0001628280-26-054306.md) | [43.0](/filings/0001628280-26-032083.md) | [35.7](/filings/0001628280-26-054306.md) |
| Current portion of debt | $m | [1.1](/filings/0001562151-23-000072.md) | [1.1](/filings/0001562151-25-000007.md) | [1.1](/filings/0001562151-24-000017.md) | [1.1](/filings/0001562151-24-000038.md) | [1.1](/filings/0001562151-24-000045.md) | [1.1](/filings/0001628280-26-018796.md) | [1.1](/filings/0001562151-25-000012.md) | [1.1](/filings/0001562151-25-000029.md) | [1.1](/filings/0001628280-25-050240.md) | [1.1](/filings/0001628280-26-054306.md) | [1.1](/filings/0001628280-26-032083.md) | [1.1](/filings/0001628280-26-054306.md) |
| Shareholders' equity | $m | [187](/filings/0001562151-24-000045.md) | [188](/filings/0001628280-26-018796.md) | [187](/filings/0001562151-25-000029.md) | [186](/filings/0001628280-25-050240.md) | [186](/filings/0001628280-25-050240.md) | [187](/filings/0001628280-26-054306.md) | [185](/filings/0001628280-26-054306.md) | [185](/filings/0001628280-26-054306.md) | [186](/filings/0001628280-25-050240.md) | [187](/filings/0001628280-26-054306.md) | [186](/filings/0001628280-26-054306.md) | [186](/filings/0001628280-26-054306.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [908 d](/filings/0001562151-24-000045.md) | [3,270 d](/filings/0001562151-25-000007.md) | [(3,657)](/filings/0001562151-25-000012.md) | [4,589 d](/filings/0001562151-25-000029.md) | [1,514 d](/filings/0001628280-25-050240.md) | [231 d](/filings/0001628280-26-018796.md) | [113](/filings/0001628280-26-032083.md) | [540 d](/filings/0001628280-26-054306.md) | [2,488 d](/filings/0001628280-25-050240.md) | [(1,722) d](/filings/0001628280-26-018796.md) | [2,357](/filings/0001628280-26-032083.md) | [6,282 d](/filings/0001628280-26-054306.md) |
| Capital expenditure | $k | [4,019 d](/filings/0001562151-24-000045.md) | [1,587 d](/filings/0001562151-25-000007.md) | [467](/filings/0001562151-25-000012.md) | [1,498 d](/filings/0001562151-25-000029.md) | [2,309 d](/filings/0001628280-25-050240.md) | [1,095 d](/filings/0001628280-26-018796.md) | [187](/filings/0001628280-26-032083.md) | [1,401 d](/filings/0001628280-26-054306.md) | [1,372 d](/filings/0001628280-25-050240.md) | [961 d](/filings/0001628280-26-018796.md) | [536](/filings/0001628280-26-032083.md) | [776 d](/filings/0001628280-26-054306.md) |
| Share repurchases | $k | [1,065 d](/filings/0001562151-24-000045.md) | [936 d](/filings/0001562151-25-000007.md) | [1,041](/filings/0001562151-25-000012.md) | [420 d](/filings/0001562151-25-000029.md) | [463 d](/filings/0001628280-25-050240.md) | [454 d](/filings/0001628280-26-018796.md) | [346](/filings/0001628280-26-032083.md) | [24.0 d](/filings/0001628280-26-054306.md) | [(19.0) d](/filings/0001628280-25-050240.md) | [0.0 d](/filings/0001628280-26-018796.md) | [0.0](/filings/0001628280-26-032083.md) | [0.0 d](/filings/0001628280-26-054306.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.3](/filings/0001562151-23-000072.md) | [21.4](/filings/0001562151-24-000017.md) | [21.4](/filings/0001562151-24-000038.md) | [21.3](/filings/0001562151-24-000045.md) | [20.9](/filings/0001562151-25-000012.md) | [20.8](/filings/0001562151-25-000029.md) | [20.8](/filings/0001628280-25-050240.md) | [20.6](/filings/0001628280-26-032083.md) | [20.6](/filings/0001628280-26-054306.md) | [20.6](/filings/0001628280-25-050240.md) | [20.6](/filings/0001628280-26-032083.md) | [20.6](/filings/0001628280-26-054306.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,586,027 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054306.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.